I've just read that they have full FDA approval and are in negotiations to sell the technology. Early expectations are conservative at $2.20 - $2.50 per share. Ask Oida, he knows the deal.
- Forums
- ASX - By Stock
- pharma
I've just read that they have full FDA approval and are in...
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online